Randomized, double-blind, placebo-controlled trial of Niaspan [niacin] in patients with overt diabetic nephropathy and moderate renal impairment
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Niacin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 12 Jul 2007 The expected completion date for this trial is now 1 Apr 2007.
- 01 Oct 2005 New trial record.